Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.60 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.55 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 3/20 | 0.52 |
| ▸ | PNMT | P11086 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.48 |
| ▸ | HTR3B | O95264 | 1/20 | 0.48 |
| ▸ | HTR3A | P46098 | 1/20 | 0.48 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.48 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.48 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | DAO | P14920 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL3789554 | 0.98 | TAAR1 (0.58) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| Formaldehyde SCHEMBL27848039 | 0.93 | TAAR1 (0.54) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL256701 | 0.86 | TAAR1 (0.56) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| Ammonia Solution, Strong SCHEMBL9427687 | 0.84 | TAAR1 (0.54) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL1374203 | 0.84 | LIPG (0.55) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL6740216 | 0.84 | TAAR1 (0.71) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL3694247 | 0.82 | LIPG (0.58) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL11658176 | 0.82 | LIPG (0.58) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL5598971 | 0.82 | LIPG (0.58) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL5271594 | 0.82 | LIPG (0.58) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109633142-A | A kind of method for building up of acute myelocytic leukemia diagnostic model and its application | 中国人民解放军第四军医大学 | 2019-04-16 | — | — | CN | claimed |
| CN-109115933-A | A method of screening Protective effects of Sini decoction myocardial ischemia effective substance | 中国人民解放军第四军医大学 | 2019-01-01 | — | — | CN | claimed |
| CN-105461896-B | A kind of bridge High Hardness Polyurethane Elastomer bearing material and preparation method thereof and application method | 黎明化工研究设计院有限责任公司 | 2018-06-08 | — | — | CN | claimed |
| EP-1902034-A1 | NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION | Glenmark Pharmaceuticals S.A. (CH) | 2008-03-26 | — | — | EP | claimed |
| US-20060281961-A1 | Functional transition metal silicates | KANUMURU RAHUL RAJU (IN) | 2006-12-14 | — | — | US | claimed |
| WO-2006129178-A1 | NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION | GLENMARK PHARMACEUTICALS S.A. (US) | 2006-12-07 | — | — | WO | claimed |
| WO-2006011000-A1 | NOVEL C6-SUBSTITUTED FURANOID SUGAR AMINO ACIDS AND IMPROVED PROCESS FOR PREPARING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-02-02 | — | — | WO | claimed |
| US-20060014939-A1 | Novel C6-substituted furanoid sugar amino acids and improved process for preparing the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2006-01-19 | — | — | US | claimed |
| CN-1234459-C | Application method of solid acid catalyst | CHINA PETROCHEMICAL CORP (CN) | 2006-01-04 | — | — | CN | claimed |
| CN-1234460-C | Regeneration process for solid acid catalyst | CHINA PETROCHEMICAL CROP (CN) | 2006-01-04 | — | — | CN | claimed |
| CN-1541768-A | Application method of solid acid catalyst | 中国石油化工股份有限公司 | 2004-11-03 | — | — | CN | claimed |
| CN-1520928-A | Regeneration process for solid acid catalyst | 中国石油化工股份有限公司 | 2004-08-18 | — | — | CN | claimed |
| US-4140695-A | Process for producing copper phthalocyanines | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 1979-02-20 | — | — | US | claimed |
| CN-117568296-A | P450 hydroxylase mutant and synthetic R-halohydrin thereof | 遵义医科大学 | 2024-02-20 | — | — | CN | disclosed |
| WO-2024030960-A2 | COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS | Kojin Therapeutics, Inc. (US) | 2024-02-08 | — | — | WO | disclosed |
| US-20240016775-A1 | ANTI-CORONAVIRUS APPLICATION OF POLY ADP RIBOSE POLYMERASE INHIBITOR | FUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD (CN) | 2024-01-18 | — | — | US | disclosed |
| US-4076746-A | FROM AN ALKYL OR ARYL HALIDE AND PHOSPHORUS SESQUISULFIDE | STAUFFER CHEMICAL COMPANY (US) | 1978-02-28 | — | — | US | disclosed |
| US-3968156-A | Process for preparing alkyl-or arylphosphonothioic dihalides | STAUFFER CHEMICAL COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
| US-3966830-A | SILICA, ALUMINA | TEIJIN LIMITED (JA) | 1976-06-29 | — | — | US | disclosed |
| US-3931218-A | HYPOGLYCEMIC ANTIRESERPINE, ANTIULCER, OGENIC, ANTIARRHYTHMIA | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240016775-A1 | ANTI-CORONAVIRUS APPLICATION OF POLY ADP RIBOSE POLYMERASE INHIBITOR | PARP3, PARP1, PARP4 | TAAR1 4878/4885SLC6A2 4625/4885SLC6A4 2710/4885 |
| US-20060014939-A1 | Novel C6-substituted furanoid sugar amino acids and improved process for preparing the same | HRH3, FFAR3, SSTR3 | TAAR1 844/4885SLC6A2 3445/4885SLC6A4 3032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.